Library

All documents

32nd VICH Steering Committee meeting, October 25, 26 & 30, 2015 (Tokyo, Japan)
Public Statements

Press Release (31 October 2015)

Download VICH/15/082


What is VICH, History and Objectives - Dr. Hervé Marion - VICH Secretariat
VICH 5 Session 1: Official Opening

Download VICH5-Session 1 H. Marion


The benefits of VICH to the VICH member countries & regions - Dr. Donald Prater - U.S. FDA
VICH 5 Session 1: Official Opening

Download VICH5-Session 1 D. Prater


The contribution of VICH to the global One Health approach - Dr. Jean-Pierre Orand - OIE
VICH 5 Session 2: Keynote Addresses

Download VICH5-Session 2 JP. Orand


The benefits of VICH to emerging countries - Dr. Sasi Jaroenpoj - Thailand/ASEAN
VICH 5 Session 2: Keynote Addresses

Download VICH5-Session 2 S. Jaroenpoj


The needs and expectations of a global industry - Mr. Carel du Marchie Sarvaas - HealthforAnimals
VICH 5 Session 2: Keynote Addresses

Download VICH5-Session 2 C. du Marchie Sarvaas


VICH/OIE training strategy - Dr. Steven Vaughn - U.S. FDA
VICH 5 Session 2: Keynote Addresses

Download VICH5-Session 2 S. Vaughn.


Trends in research and development of new veterinary drug substances and products - Dr. Mark Micallef - Zenoaq, Japan
VICH 5 Session 4: Voice of Industries

Download VICH5-Session 4 M. Micallef.